Professional Documents
Culture Documents
THE FUTURE
Nanotechnology is an important field of
medern research dealing with synthesis, strategy
and manipulation of particle’s structure ranging
from approximately 1 to 100nm in size.The prefix
‘nano’ is referred to a Greek prefix meaning ‘dwarf’
or something very small and depicts one thousand
millionth of a meter (10−9 m).
Nanotechnology originated from Richard
Feynman’s 1959. The term was coined by Norio
Taniguchi ,a Japanese scientist was the first to use
and define the term “nanotechnology” in 1974 as:
“nanotechnology mainly consists of the processing of
separation, consolidation, and deformation of
materials by one atom or one molecule”. The invention
of the scanning tunneling microscope in 1981 and the
establishment of the National Nanotechnology
Initiative in 2000 accelerated its development and
application.
The Nanoscale refers to a size range of
approximately 1 to100 nanometers, where
materials exhibit unique properties and
behaviors due to quantum effects and
increased surface area.
The Nanoscale in Nanotechnology lies in its
ability to unlock unique properties and
phenomena. Manipulation materials at this
scale allows for the development and novel
application in medicine, electronics, energy,
and materials science, revolutionizing
industries and driving technology
advancements.
Nanoscale materials have far larger
surface area-to-volume ratio than bulk
materials. As surface area per volume
increases, materials can become more
reactive.
The use of Nanotechnology in medicine offers
some exciting possibilities.Some techniques are
only imagined, while others are at various stages
of testing, or actually being used today.
ECONOMICS
THERAPY
the brain
RISKS
Once in the blood stream, nanomaterials can circulate
throughout the body and can lodge in organs and
tissues including the brain, liver, heart, kidneys, spleen,
bone marrow and nervous system. Once inside cells,
they may interfere with normal cellular function,
cause oxidative damage and even cell death
CHALLENGES:
The first significant challenge for nanoregulators and policymakers is that the public
are generally supportive of nanotechnology, but they feel uncertain about whether
existing regulations are sufficient. Uncertainty about regulations could lead to future
public rejection of nanotechnology if consumers feel that risks are high and
unchecked by regulations. In addition, this public uncertainty about nanoregulations
could result in the public shying away from some existing commercial nanotechnology
products that are relatively safe and have low risk levels.
THANK YOU